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Abstract
In vitro evidence indicates that PGE2 production in renal
medullary interstitial cells is stimulated by ADH and the PGE2 in¬
hibits the effect of this hormone on water transport.

However,

factors modulating renal production and excretion of PGE2 in states
of altered water balance have not been well defined in vivo.

There¬

fore, studies were designed to measure UpQE^V following endogenous
ADH, exogenous ADH without dehydration, and dehydration without ADH
using normal Sprague-Dawley (N) and Brattleboro (DI) rats.
(Institut Pasteur).

UpgE^

Urine was collected on ice because thin layer

chromatography indicated that room temperature (24 hrs) resulted in
conversion of 17% of PGE2 to PGA2.

Stimulation of endogenous ADH by

18 hr dehydration in N rats (U max 2673±132 mOsm/kg) increased
UpGE2^ ^rom ?.9±0.7 to 11.2 ± 0.9 ng/12 hrs (p<0.05).

Low dose vaso¬

pressin (600 mU/kg body wt/day) was given to DI rats for 7 days.

By

day one, UpQ^V increased from 6.9 ±3.6 to 29.3 ±4.7 ng/24 hrs (p<.005),
while Uosm increased from 99±4 to 203 ±41 mOsm/kg.

UPq£2V increased

further on day 4 to 61 .4 ±9.2 ng/24 hrs (p<.005 compared to day 1)
without further increase at day 7.

The effect of dehydration in the

absence of ADH was investigated in DI rats by collecting urine during
the 4th through 16th hr of dehydration, while body wt decreased by
5.7±0.6 (4th hr) to 15.5 ±1.0% (16th hr).

Upg^V increased (p<.001)

from 7.9 ±1.5 ng/12 hr at baseline to 23.3± 2.8 ng/12 hr during de¬
hydration with UQSm increasing from 103 ± 6 to 502 ±56 mOsm/kg.

These

studies demonstrate that in addition to ADH, dehydration alone is a
potent stimulus to the renal productior and excretion of PGE2, an
effect which may further modulate that action of ADH on the collecting
duct.

v

Introduction
The single most important factor influencing renal water
metabolism is antidiuretic hormone.

This peptide hormone is synthe¬

sized by cells in the supraoptic and paraventricular nuclei of the
hypothalamus and stored in the posterior pituitary.^

Release of

antidiuretic hormone is controlled primarily by plasma osmolalityJ58
For plasma osmolality greater than 280 mOsmoles per kilogram water
there is a positive linear correlation between plasma antidiuretic
hormone concentration and plasma osmolal ity.^’

128

yj^ function¬

al characteristics of the osmoreceptor in the anterior hypothalamus
may be modified further by changes in circulating intravascular volume
and pressure.^* 127

unlike the exquisite sensitivity of the osmore¬

ceptor to variations in solute concentration, substantial changes in
volume are required to alter the release of antidiuretic hormone.^6
Circulating antidiuretic hormone acts on renal collecting ducts
and late segments of the distal convoluted tubule.

Increased water

permeability in isolated collecting tubules occurs only when the
hormone is on the peritubular side of the cel Is.69> 70

Retrograde

injection of vasopressin into the collecting system of rats produces
no antidiuretic action.^8
The basolateral plasma membranes of the collecting duct cells
have a vasopressin specific receptor which is associated with an
adenyl cyclase that catalyzes the formation of cyclic adenosine
3', 5'-monophosphate (cyclic AMP) from adenosine

-1-

5'-triphosphate.25,126

-2-

Binding of vasopressin to the receptor activates the adenyl

cyclase.

The changes in water permeability after vasopressin stimulation are
attributed to the increase in concentration of cyclic AMP.1^3

Ex-

ogenous cyclic AMP mimics the actions of antidiuretic hormone.
Methylxanthine inhibition of cyclic AMP-phosphodiesterase, the
enzyme which catalyzes the breakdown of cyclic AMP, results in accumu¬
lation of endogenous cyclic AMP in renal tissue after vasopressin
stimulation and increases the hydro-osmotic effect of the hormone.^9*^
Dousa and colleagues have proposed that the permeability of
the luminal membrane is associated with a specific membrane protein
which is a substrate for cyclic AMP-dependent protein kinase.

Phos¬

phorylation of the protein leads to a change in membrane structure
and increased water permeability.^2

Exposing rat renal medullary

slices to vasopressin activates protein kinase.^

This activation is

proportional to the concentration of cyclic AMP.^l

The protein phos¬

phatase for dephosphorylation is also present in renal medulla;
however, the subcellular localization of both the specific protein
substrate for the vasopressin activated protein kinase and the
specific protein phosphatase has not been determined.

A causal re¬

lationship between this system and the vasopressin-induced changes
in water permeability remains to be established as we11.^0* 134
The cellular action of antidiuretic hormone requires the
integrity of microtubules and microfilaments.

Drugs like colchicine,

vinblastine or podophyllotoxin which disrupt microtubules or prevent
their assembly block vasopressin- or cyclic AMP-induced osmotic water
flow without altering sodium transport in the toad urinary

bladder.153

-3-

The antidiuretic action of vasopressin in vivo is also antagonized
by these agents, but they had no effect on adenylate cyclase, cyclic
AMP-phosphodiesterase, or cyclic AMP-dependent protein kinase from
rat renal

medulla.^2

These findings suggest a role for micro¬

tubules in mediating the action of vasopressin on the distal nephron
and also that their involvement occurs after the cyclic AMP effects.
Microfilaments are cytoplasmic organelles composed of protein
with biochemical properties similar to muscle actinJ2

The micro¬

filaments terminate close to or may be directly attached to cell
membranes.^

The antibiotic cytochalasin B which disrupts micro¬

filaments reversibly inhibits the hydro-osmotic effects of both
vasopressin and exogenous cyclic AMP besides blunting the vasopressinstimulated increase in endogenous cyclic AMP.37
When toad urinary bladder is exposed to vasopressin the lateral
intercellular spaces widen suggesting an intercellular pathway in
transepithelial water

flow.86’

156

jf the toad bladder is first ex¬

posed to cytochalasin B and then to vasopressin striking morphologic
changes occur.

The most pronounced changes include accumulation of

giant vacuoles intracellularly, cell swelling, and disruption of
microfilaments along the basolateral membranes.87» 141

since the

intercellular tight junctions are impermeable to water^S these
studies suggest that microfilaments are involved in vasopressininduced transcel1ular flux of water by altering properties of the
basolateral plasma membranes.
Other drugs also interfere with the cellular action of anti¬
diuretic hormone.

Lithium impairs

vasopressin-stimulated water

-4-

transport in the toad bladder in vitro and in rat and dog kidney in_
vivoJ^» 137

jhus, lithium produces a nephrogenic diabetes insipidus

by impeding steps proximal and distal to cyclic AMP generation:

both

the vasopressin-stimulated adenylate cyclase and a cyclic AMPdependent protein kinase are inhibited.^
Demeclocycline inhibits both vasopressin-induced and cyclic
AMP-induced hydro-osmotic response of toad bladderJ52

Besides in¬

hibiting vasopressin-stimulated adenylate cyclase and cyclic AMP
protein kinase in vitro,demeclocycline appears to cause nephro¬
genic diabetes insipidus at least in part by binding to a specific
epithelial cell protein required for the action of antidiuretic
hormone.^, ^1 » 136
The sulfonylurea chlorpropamide causes increased release of
endogenous antidiuretic hormone

and potentiation of the renal

action of submaximal doses of vasopressin.79» 112, 113

yhe drug has

no effect on water flow in the absence of vasopressin^ 0r in the
presence of maximal levels of the hormone.174

Paradoxically, chlor¬

propamide inhibits the effects of cyclic AMP on water transportT9*
Early studies of drug-induced disorders of antidiuretic
hormone action did not adequately investigate the possible role of
naturally occurring substances which could modulate the renal response
to antidiuretic hormone ijy vivo.

For example, only recently have the

prostaglandins been implicated in the mechanism of chlorpropamideinduced enhancement of vasopressin action.l75

yhe discovery of high

concentrations of prostaglandin E2 and the enzymatic machinery for
prostaglandin synthesis in renal medulla made it seem plausible that

5-

-

prostaglandins have a function in modulating water excretion.
Credit for the original description of the class of fatty
acids now known as prostaglandins belongs to von EulerJ^Q

it was

not until twenty-five years later that Bergstrdm and Sjtivall succeeded
in isolating these compounds^* ^ and elucidating their structures.^
The prostaglandins are twenty-carbon fatty acid derivatives of
prostanoic acid (Figure 1).

All the prostaglandins possess a C-15

hydroxyl group and a C-l3:C-l4 trans double bond.

The discrete

classes -- E, F, A, B, C, and D -- are distinguished by the functional
groups on the cyclopentane ring (Figure 2).

The individual prosta¬

glandins differ further in the degree of unsaturation of the side
chains, designated by the subscripts 1, 2, or 3.

The termsaors

refer to the configuration of the C-9 hydroxyl group, the a configura¬
tion being cis to the carboxyl function.
Although recent evidence suggests that prostaglandin A290 and
prostaglandin

as Well as the related compounds thromboxane A2^5

and prostacyclin^ are present in renal tissue, prostaglandin E2 and
prostaglandin F2ct have long been considered the principal renal
prostaglandins.
The biosynthetic pathway for the renal prostaglandins is de¬
picted in Figure 3.

The fatty acid precursor 5, 8, 11, 14-eicosa-

tetraenoic acid (arachidonic acid) is released from the cellular
phospholioid stores by phospholipase A.

The conversion of arachi¬

donic acid into prostaglandins is catalyzed by prostaglandin synthe¬
tase in the presence of molecular oxygen.

The synthetase a microsomal

enzyme complex,27 consists of a cyclo-oxygenase, a peroxidase, and

6-
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an endoperoxide isomerase or

reductase

Briefly, arachidonic acid undergoes oxygenation and cyclization in the presence of cyclo-oxygenase to form the endoperoxide
intermediate prostaglandin G2.

Prostaglandin G2, in turn, is con¬

verted to a second endoperoxide prostaglandin H2 via peroxidase.

At

this point, the biosynthetic pathway diverges to give prostacyclin,
thromboxane A2, prostaglandin D2, prostaglandin F2a, or prostaglandin
E2.

Specifically, prostaglandin E2 is produced by the action of endo¬

peroxide isomerase on prostaglandin
There is some evidence that other tissues have the enzymatic
capability of converting prostaglandin E2 to prostaglandin A2-^4, ^2
No studies have convincingly demonstrated prostaglandin E2 dehydro¬
genase in renal medullary tissue.24, 90, 149

whether the small

amounts of prostaglandin A2 found by some workers is due to nonenzymatic dehydration of prostaglandin E2 to prostaglandin A23 and
that prostaglandin

1S indeed an artifact of the isolation pro¬

cedures remains controversial.^’ 93
Besides possessing the ability to synthesize prostaglandins,
the kidney also has the capacity for their degradation.

The enzymes

responsible for prostaglandin E2 metabolism in the kidney include
15-hydroxydehydrogenase (types I and II), a-13 reductase, and prosta¬
glandin E2-9-keto-reductase.
The 15-hydroxydehydrogenases are both cytoplasmic enzymes.^
Type I uses NAD+ as a cofactor and is located primarily in the renal
cortex.

Type II is more abundant in renal medulla where its specific

activity is twice that in cortex.

NADP+ is the cofactor for the type

7-
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II dehydrogenase.96
Prostaglandin E2 can be reversibly converted to prosta¬
glandin F2

by prostaglandin E2~9-ketoreductase, an NADP+-dependent

soluble enzyme.95 There is interspecies variability in the distribution
of the prostaglandin E2~9-keotreductase in the kidney^* 143 as wen
as differences in the molecular properties of the enzymes from tissue
to tissue.143
The rat kidney also has a prostaglandin F2a-9-hydroxydehydrogenase.125

13,

]4-dihydro-15-keto-prostag1 and in F2ra can be dehy¬

drogenated via this enzyme to 13, 14-dihydro-15-keto-prostag1 and in E2,
a urinary metabolite of prostaglandin E2.

Hence, measurement of uri¬

nary metabolites of prostaglandin E2 may not be a reliable index of
prostaglandin E2 metabolism.
Although isolated reports suggest that prostaglandin E2 infused
into the carotid artery inhibits water diuresis^ ancj that intracisternal prostaglandin results in increased plasma antidiuretic
hormone activity,^ recent investigations have focused on the action
of intrarenal prostaglandins to regulate vasopressin effects on water
transport.
Very early work was performed on the toad urinary bladder.
Basal water transport in the toad bladder is not affected by prosta¬
glandin E].^

However, prostaglandin E-j uniformly antagonizes the

permeability response of toad bladder to vasopressin and theophylline. ’

*

In these experiments prostaglandin E] does not

influence the hydro-osmotic effect of exogenous cyclic AMP.^» '23
Polyphoretin phosphate, a competitive antagonist of prostaglandins.

8-
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but not indomethacin counteracts the toad bladder response to vasopressin in the presence of exogenous prostaglandin E-j. »

In fact,

in the absence of prostaglandins the competitive inhibitor exhibits a
slight but measurable enhancement of vasopressin effects on water
permeabilityJ24

Inhibition of endogenous prostaglandin E2 synthesis

by indomethacin increases the osmotic water flow response to submaximal doses of vasopressin and cyclic AMP.65
Intravenous infusion of prostaglandin E-j results in urinary
excretion of the corresponding metabolites.6^ 74

Excretory clearance

of intact prostaglandin from the circulation is negligible.6?

Frolich

and co-workers showed that unilateral renal artery infusion of the
prostaglandin precursor sodium arachidonate or of angiotensin leads
to an ipsilateral increase in urinary excretion of prostaglandin E
as measured by competitive protein binding.62
Though previous investigators found essentially no prosta¬
glandin E2 activity in extracts of rabbit renal cortex,^ Larsson and
Anggard detected measurable amounts of prostaglandin E2 in cortex.
However, these investigators confirmed that prostaglandin E2 bio¬
synthesis is ten times higher in the medullary region of the kidney
compared to the cortex.92

More recently, evidence from stop-flow

studies in dogs suggests that the site of entry of prostaglandin E
into tubular fluid may be the loop of HenleJ66

It remains unclear

if the bioassay utilized by Crowshaw and Szlyk was sensitive enough
to detect the minute quantities of cortical prostaglandin E2.
In microdissected slices of rabbit papilla, 39 to 42 percent
of prostaglandin synthetase activity is associated with cells of the

9-
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collecting duct, but substantial activity remains in papillary slices
lacking these cells.26

This finding is not in total agreement with

previous histochemical data that localized prostaglandin synthetase
exclusively to collecting ducts.22

By immunofluorescence tech¬

niques cyclo-oxygenase is found primarily in the collecting duct but
also to a lesser extent in the interstitial cells of the renal medulla
of the ratj26

Both renomedullary interstitial cells26 and collecting

duct cells26 possess peroxidase activity.

Whether this peroxidase

is indeed the one involved in prostaglandin biosynthesis remains to
be proven conclusively.
Similar cytochemical studies have demonstrated 15-hydroxydehydrogenase in cells of the thick ascending limb and the distal
convoluted tubule in the cortex.

1 IQ

In vitro prostaglandin E-j is

concentrated by renal cortical slices with a tissue to medium ratio
of up to six to one.

No such uptake is exhibited by medulla.22

Thus,

the prostaglandin E2 found in the cortex may in fact have been syn¬
thesized in the medulla and transported via tubular fluid to the
cortex where it could be concentrated and then metabolized by the
15-hydroxydehydrogenase.
In the red hamster prostaglandin E-j does not inhibit renal
adenyl cyclase activity directly but does antagonize the vasopressinstimulated increase in the enzyme's activityJ66

Experiments with

low concentrations of prostaglandin E] in rat rerial medulla corrobor¬
ate these findings.^

The permeability response of isolated perfused

collecting tubules to vasopressin decreased approximately fifty per¬
cent in the presence of prostaglandin E], whereas tubules exposed to

10-
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prostaglandin E] alone displayed an increased water reabsorption.^
There is evidence that prostaglandin E diminishes the
permeability of the collecting duct in vivo, hence producing a rise
in free water clearance.^88

Inhibition of endogenous prostaglandin

synthesis potentiates the peripheral action of vasopressin in con¬
scious dogs88 and in anesthetized hypohysectomized dogs undergoing a
water diuresis.8

Prostaglandin inhibition may decrease medullary

blood flow thereby enhancing the osmotic gradient for water reabsorpOO

tion.

The in vitro potentiation of vasopressin by prostaglandin

inhibition could be accounted for on this purely hemodynamic basis
without altering the cellular action of vasopressin.

However,

indomethacin also potentiates the action of vasopressin in conscious
rats in which renal hemodynamics did not changeJ82

Also, in renal

papillae snap frozen in liquid nitrogen for cyclic AMP assay, the
vasopressin-stimulated increase in cyclic AMP was enhanced after
treatment with indomethacin^8* 1°2 -- further evidence to support the
hypothesis that prostaglandins interfere with the cellular action of
vasopressin to generate cyclic AMP.
Infusion of prostaglandin E-j uniformly increases urine flow
and free water clearance and decreases urine osmolality while renal
blood flow and solute excretion simultaneously increase J8> ?2> 102,135, 151
In agreement with these findings, water restricted dogs have diminished
free water reabsorption after prostaglandin E] infusion into the renal
artery.^2

These effects require the presence of endogenous anti-

diuretic hormone.2^

Although an increase in the distal delivery of

tubular fluid to the diluting segment of the nephron can account for

-li¬

the increase in water excretion, this does not exclude the possibil¬
ity that prostaglandin E also inhibits the action of antidiuretic
hormone on a cellular level.

This hypothesis is substantiated by

experiments showing that prostaglandin E-j administration results in a
greater decrease in free water reabsorption and hypotonic urine than
acetylcholine, a vasodilator, despite equivalent solute excretion in
saline expanded dogsJ^^

Recently, Stygles and Hood have proposed

that prostaglandin E2 antagonizes antidiuretic hormone by increasing
intracellular free calcium ion which then results in disaggregation
of the microtubular apparatus.^4
Additional evidence that in situ prostaglandins play a role
in the renal water transport mechanism is provided by experiments in
which rabbit renomedullary interstitial cells grown in tissue culture
synthesize

prostaglandins

173

using this model system, Zusman

and Keiser subsequently demonstrated that prostaglandin E2 biosynthe¬
sis is stimulated by the presence of

J^4

vasopressin

Both vaso¬

pressin and dDAVP (1-desamino-8-d-arginine vasopressin) increased
QQ

rabbit urinary prostaglandin E2 excretion in vivo.
Prostaglandins may also be involved in the maintenance of the
medullary solute gradient.

Rat renal papillary sodium concentration

nearly doubles while chloride ion concentration increases sixty
percent thirty minutes after treatment with prostaglandin synthetase
inhibitors.

Medullary plasma flow remains constant.^

Thus, prosta-

glandins may modulate net renal water transport by this mechanism
as wel1.
Much work has been done to show that prostaglandins are in-

12-

-

volved in regulating renal water transport via the peripheral action
of antidiuretic hormone; however, some investigators maintain that
many of the results can be explained on the basis of intrarenal
hemodynamic changes produced by the prostaglandins.^

In vivo studies

have been particularly complicated by variations in renal blood flow
and renal vascular resistance which, in turn, may influence net water
transport.

In many instances it is unclear whether these hemodynamic

changes are indeed the mechanism whereby prostaglandins exert their
effects or the experimental conditions induced the changes in blood
flow.

For example, anesthetized acutely operated animals show a

distinct decrease in renal blood flow after inhibition of prosta¬
glandin synthetase.^5

This decrease in renal blood flow can be

blocked by prior treatment with sar^, ala^-angitensin II, an antagonist of angiotensin II.

1 -50

In contrast, conscious dogs given indo-

methacin have no change in basal renal blood flow.

148

Thus stimula¬

tion of the animals can lead to release of angiotensin which in itself
is known to increase renal prostaglandinsJ, ^
a similar effect.

Norepinephrine has

It is thought that experimental manipulation can

potentiate the inhibitory actions of the prostaglandin synthetase
l rr

antagonists.1

Prostaglandin E infusions also affect the distribution of
renal blood flow.
glandin

Increased renal blood flow is seen with prosta¬

, prostaglandin E2, and arach:donic acid administration in

dog^’ ^ and rat.^5

The magnitude of these vascular changes is more

profound in the inner cortex than the outer cortex,^ but other vaso¬
dilators also show a preference for augmenting inner cortical blood

13-
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flow.142

It may be that prostaglandins mediate the effects of these

vasodilators as well.^4

Conversely, with the inhibition of

prostaglandin synthesis the attending decrease in renal blood flow
is accompanied by redistribution of flow to outer cortical nephrons.88
Solez and colleagues have measured a diminished medullary blood flow
in rats after indomethacin treatment.*40
Much of the information on renal prostaglandins and their role
in renal physiology has been gained through in vitro studies, and
other work has largely involved infusions of prostaglandin E^ which
is not found in the kidney.

The role of endogenous renal prosta¬

glandin E2 in mammalian systems in vivo has only recently been
examined.

Efforts in this area have largely been hindered by

methodological problems in purifying and measuring the minute
quantities of prostaglandins in physiological fluids.
Numerous and diverse techniques have been developed for
isolation and quantitation of prostaglandins:

gas liquid

chromatography-mass spectroscopy,0 competitive protein binding,
isotope derivative methods,28 bioassay,^8 and radioimmunoassay.80
Although gas liquid chromatography-mass spectroscopy is the most
specific and accurate method available, it requires expensive
equipment and most importantly lacks the sensitivity for measuring
picogram quantities of prostaglandins in physiological fluids.
Radioimmunoassay appears to be the most promising analytical
tool at this time although there are several pitfalls.

The

sensitivity of radioimmunoassay is very high (to concentrations of
five and ten picograms per milliliter); however, its specificity

14-
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may often fall short for certain applications.

This has been a

problem especially with regard to developing antisera to prostaglandins
of the E series.

Many investigators have attempted to prepare

antibodies to the prostaglandin E's with variable
success.44 ’ 80, 81, 82, 83, 131
glandin E^ and prostaglandin

Cross reactivity between prosta¬
and between these prostaglandins

and their metabolites31 has been the major impediment and is the
reason radioimmunoassay tends to overestimate the amount of
prostaglandin E.
In addition, conjugation of prostaglandin E to the carrier
protein via a reaction with carbodiimide results in significant
quantities of prostaglandin B being formed; thus, the resultant
antiserum possesses considerable affinity and cross reactivity with
prostaglandin B.33

Some investigators have circumvented this

problem by quantitatively converting prostaglandin E to prosta¬
glandin B in a controlled reaction and then assaying the mixture
for prostaglandin B activity.131
The development of a highly specific anti-prostaglandin E2
antiserum at the Institut Pasteur44 enables picogram quantities
of prostaglandin E2 in urine to be measured accurately after treatment
of the urine with amber!ite33 and silicic acid column chromatography.31
The objective of the present experiments was to establish
a sensiti/e radioimmunoassay capable of measuring urinary prostaglandin
excretion during water diuresis and antidiuresis in small rodents.
The effects of temperature and time on the stability of prostaglandin E2
in urine was examined to determine the ideal conditions for collection
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and storage of urine prior to radioimmunoassay.

Measurement of

urinary prostaglandin E£ was determined following physiological
stimulation of endogenous vasopressin in the Sprague-Dawley rat.
Serial changes in urine osmolality and urinary prostaglandin
excretion were also investigated in the Brattleboro strain of rats
with congenital diabetes insipidus given physiological doses of
exogenous vasopressin.

The excretion of prostaglandin E? during

dehydration in the absence of antidiuretic hormone was also investi¬
gated.

These experiments were designed to determine the relationship

between urinary excretion of prostaglandin E2 and the hydro-osmotic
action of antidiuretic hormone.

Methods and Materials
Methods
Effects of storage temperature and time on the stability of
prostaglandin Eg in rat urine
The effects of storage temperature and time on the conversion
of urinary prostaglandin

to prostaglandin

thin layer chromatographic studies.

were determined in

Adequate urine volume for all

studies was obtained from a 24-hour collection in a 253 gm
Brattleboro rat with free access to water and standard ground Purina
rat chow.
The urine was partitioned into 1.0 ml fractions in 50 ml
conical tubes.

At time zero (tQ), approximately 30,000 cpm

H-prostaglandin E2 in 10 yl ethanol were added to each sample and
mixed thoroughly by vortex agitation.
one of three groups:

Samples were then assigned to

room temperature (22° ± 3°C), standard

refrigerator temperature (4°C), or freezer temperature (-20°C).
After an interval of time (tn) measured from tg, varying from
zero minutes to 14 days, each fraction was extracted with 8.0 ml
ethyl acetate.

Extraction of frozen urines was accomplished at the

moment the samples had thawed completely.

For these samples, tn

equaled the time elapsed from tg to initiation of the thawing process.
The ethyl acetate extract was evaporated under nitrogen at room
temperature and the residue was dissolved in 500 yl ethyl acetate:
methanol, 1:1, v:v.

The concentrated extract was spotted on silica

16
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gel thin layer chromatography plates.
containing 100

yg

prostaglandin

As markers, duplicate standards

200

yg

prostaglandin E2 and 100

yg

prostaglandin F2a ™ 300 y1 ethanol were spotted on peripheral channels
of each plate.

Each 20 cm x 20 cm

plate accomodated six samples.

To control for any ^H-prostaglandin

^

in the exogenous tracer

that might interfere with the estimates of conversion of prosta¬
glandin E2 to prostaglandin A^, a 10

yl

sample of ^H-prostaglandin E2

in ethanol was plated directly (control #1).

To demostrate that the

method was capable of detecting conversion of prostaglandin E^ to
prostaglandin A2, a second control (control #2) was prepared.

A urine

sample with 3H-prostaglandin E2 was titrated to pH 3 with 0.10 N
hydrochloric acid prior to extraction and plating; this procedure is
known to accelerate the conversion of prostaglandin E2 to prostaglan¬
din A2.3
Each thin layer chromatography plate was developed twice in
the same direction with chloroform:methanol:acetic acid:water,
90:6:1:0.75, v:v:v:v.

The prostaglandin markers were sprayed with 10%

(w/v) phosphomolybdic acid in ethanol and visualized by dry heat.
Zones with relative Rf's corresponding to the markers for prosta¬
glandin A2, prostaglandin E2, and prostaglandin F2a were scraped and
vacuum aspirated into 6-inch Pasteur pipettes fitted with pyrex wool.
The remaining areas of gel were treated similarly.

The silica gel was

eluted into scintillation vials with 6.0 ml methanol and samples were
taken to dryness under air.

To each vial was added 10 ml Aquasol and

the samples were counted for five minutes.
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Effects of endogenous antidiuretic hormone on urine osmolality
and urinary excretion of prostaglandin E2 in the Sprague-Dawley rat
Animals employed in these experiments were male Sprague-Dawley
rats weighing between 255 gm and 275 gm.

Rats were caged in pairs

and allowed Purina rat chow and water ad 1ibitum until the beginning
of the experiment.
At the onset of an experiment, seven rats were weighed and
placed into individual clean metabolic cages.

The animals were

allowed up to 20 gm per day of laboratory prepared food (470 gm
sucrose, 300 gm casein, 100 gm lard, 50 gm corn oil, 24.4 gm NaCl,
11.6 gm K2HPO4, and 50 gm vitamin-mineral mix) providing 8 milliequivalents sodium per day.

Free access to water was permitted.

As

prostaglandins are known to be involved in the mechanism of renin
release,^8* 162, 163, 164 a controlled high sodium intake was utilized
to maintain plasma renin at relatively steady low levels.
On the eighth day, while continuing the stipulated diet
each cage was equipped with a clean clamped funnel to collect all
voided urine under mineral oil for 12 hours.

At the inception of the

urine collection the bladder of each rat was emptied by external
massage and this urine was discarded.

The procedure was repeated at

the termination of the collection period and this urine combined with
the volume accumulated in the metabolic funnel.

Fecal contamination

was prevented by interposing a fine mesh wire screen between the rat
and the urine.

Throughout the 12-hour period the amassed urine was

kept at 0°C by immersing the funnels in ice-water baths replenished
with ice every four to six hours as needed.

After immediate deter-
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mination of urine volumes, 7 ml aliquots of the specimens were frozen
at -20°C for subsequent measurements of osmolality, creatinine, and
prostaglandin E2On the tenth day water was withdrawn from the rats.
animals were dehydrated for 30 hours.

The

In order to obtain adequate

urine during maximum stimulation of antidiuretic hormone secretion,
urine was collected only between the 18th and 30th hours (12-hour
collection).

The collection procedure and handling of specimens

were identical to that outlined above for the baseline determination.

Effects of exogenous vasopressin on urine osmolality and
urinary prostaglandin E? excretion in the Brattleboro rat
Twelve 240 gm to 275 gm male Brattleboro rats which had
previously been fed Purina rat chow pellets and water ad libitum
were assigned to individual metabolic cages and allowed five days for
acclimatization.

During this time and the seven-day experimental

period, the animals were offered water ad libitum and fed 15 gm ground
Purina rat chow per day providing 1.5 milli-equivalents sodium per
day.
On day one and each day thereafter for seven days, a subcutaneous
injection of vasopressin tannate in oil, 600 mU per kilogram body weight
was administered.

Exactly 24 hours after the initial injection, the

second injection was given.

The rats were immediately induced to

void by external bladder massage and a 24-hour urine collection was
begun.

The procedure for collection and storage of urine was identical

to that for the 12-hour collection detailed in the preceding section.
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Similar 24-hour collections were completed on the fourth and seventh
days of vasopressin administration.

All rats were weighed at the

beginning of the experiment and on the seventh day.
Six hours after the final urine collection the animals were
anesthetized with an intraperitoneal injection of Inactin, 100 mg
per kilogram body weight.

The inferior vena cava was surgically exposed

and venous blood was collected into non-heparinized vacutainer tubes.
The serum was stored at -20°C for subsequent creatinine determinations.

Effects of dehydration alone on urine osmolality and
urinary prostaglandin

excretion in the Brattleboro rat

Eleven male Brattleboro rats between 200 gm and 300 gm were
caged in pairs and offered Purina rat chow pellets and water ad
1ibitum.

Five days prior to an experiment the rats were transferred

to individual clean meatbolic cages and permitted to acclimate to
the surroundings.

During this time and the experimental period the

animals were given 15 gm ground Purina rat chow per day and water
ad libitum unless otherwise specified.
On the sixth day the rats were weighed and a baseline 12-hour
urine collection was performed as described earlier in this text.
Volume measurements were done on samples which were then frozen
at -20°C.
The subsequent day the rats were weighed once again and water
was withdrawn.

After four hours dehydration, the animals' weights

were checked and another 12-hour urine collection was executed.

The

rats continued to be deprived of water during the collection period.
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At the end of 16 hours dehydration the rats were reweighed.

Urine

volumes were measured and the specimens were frozen at -20°C for later
measurements of osmolality, creatinine and prostaglandin E2.
The rats were anesthetized with Inactin as in the previous
group and blood obtained for plasma creatinine.

Quantitation of urinary prostaglandin E2 by radioimmunoassay
On the day of assay for prostaglandin E2 the frozen urine
specimens were thawed at room temperature.

Then, 5.0 ml aliquots

were immediately pipetted into individual 50 ml Nalgene screwcap
centrifuge tubes.

A 5.0 ml phosphosaline buffer blank and a control

sample with 1.0 ng prostaglandin E2 in 5.0 ml phosphosaline buffer
were treated similarly.
For subsequent calculation of recovery, expressed as percent
prostaglandin E, approximately 2000 cpm ^H-prostaglandin E^ in 50 yl
ethanol were introduced into each sample and into duplicate
scintillation vials for determination of total recovery.
were vortexed.

The tubes

After each specimen had received 1.0 gm Amberlite CG-50,

the tubes were placed at a 45 degree angle into a Dubnoff Mechnical
shaker and agitated at the maximum setting (#9) for 20 minutes at room
temperature.

The tubes were then centrifuged at 5000 g for 10 minutes

at 4°C, and the aqueous supernatant was aspirated and discarded.
Elution of

prostaglandins from the resin was accomplished by two

washings (shaking 20 minutes at room temperature as above) with 5.0 ml
methanol.

Each extraction was followed by centrifugation as before.

The organic phase was transferred to a 15 ml screwcap culture tube.
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The combined methanol layers from the respective samples were dried
under nitrogen at room temperature in an N-Evap for to a final volume
of 1 ml to 3 ml.
After acidification with 25 pi 1.0 N hydrochloric acid, ex¬
traction with 8.0 ml ethyl acetate, and centrifugation at 1000 g for
10 minutes at 4°C, the top phase was pipetted into a clean 15 ml
screwcap culture tube.

The solvent was evaporated to dryness under

nitrogen, and the residue was resuspended in 0.20 ml solvent IV
(benzene:ethyl acetate:methanol, 60:40:10, v:v:v) and vortexed vigor¬
ously.

Then 0.80 ml solvent I (benzene:ethyl acetate, 60:40, v:v)

was added and the solution vortexed again.

The prostaglandin solu¬

tions were capped and stored under nitrogen at -20°C overnight.
Isolation and purification of the prostaglandins was carried
out by silicic acid column cnromatography.

One 16 cm x 1 cm Brock's

mini-column with a piece of Whatman GF/A filter paper cut to fit the
base with a #5 cork borer was set up for each separate sample.

A

slurry of 500 mg washed silicic acid in 5.0 ml solvent II (benzene:
ethyl acetate:methanol, 60:40, v:v:v) was carefully transferred to
the mini-columns by Pasteur pipette.

When the solvent meniscus had

reached the level of the silicic acid, the samples were applied to
the columns.

The fraction containing both prostaglandin A and

prostaglandin B was eluted from the column with 4.0 ml solvent I and
discarded.

Next, 13.0 ml solvent II were utilized to elute the

prostaglandin E; this fraction was collected in 20 ml screwcap vials.
The solvent was evaporated to dryness under nitrogen, and the prosta¬
glandin E redissolved in 1.0 ml ethanol.
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To assess recovery an 0.10 ml aliquot of this ethanolic
solution was pipetted into 10 ml Aquasol in a scintillation vial
and counted for ten minutes.

Yield was expressed as percent of

total recovery.
The remainder of the prostaglandin E in ethanol was stored
under nitrogen at -20°C until the time for quantitation of prosta¬
glandin E2 by radioimmunoassay the next day.
Duplicate 0.10 ml aliquots of the prostaglandin E solutions
were pipetted into 10 mm x 75 mm RTU culture tubes.

An occasional

sample required 0.20 ml aliquots in order to obtain a quantity of
prostaglandin E2 within the range of the standard curve.

A standard

curve was pipetted from stock solutions (SS) of prostaglandin E2 in
ethanol:

SS 1 contained 10.0 ng prostaglandin E2 per 1.0 ml ethanol,

SS 2 had 1.0 ng prostaglandin E2 per 1.0 ml ethanol.

Appropriate

volumes of the stock solutions were pipetted in duplicate to obtain
eight values (SI to S8) ranging from 1 pg to 1 ng prostaglandin E2
as shown in Table 1.

Two tubes each for total counts (TC), non¬

specific binding (NSB), and initial binding (Bq) were also set up at
this time.
After complete evaporation of the ethanol in a vacuum over
at 15 mm Hg at room temperature, 0.10 ml phosphosaline buffer with
0.10% (w/v) gelatin was measured into each tube and vortexed.
Ethanol in which the

H-prostaglandin E^ was stored was evaporated

under nitrogen and the -^-prostaglandin E2 was brought up in a volume
of phosphosaline buffer with gelatin so that 0.10 ml phosphosaline
buffer with gelatin would deliver approximately 10,000 cpm to each

24

-

sample.

-

All samples were again vortexed.

Into all except the TC

and NSB tubes was pipetted 0.10 ml anti-prostaglandin E2 antiserum.
The TC and NSB tubes received a second 0.10 ml phosphosaline buffer
with gelatin without the antibody.

After vortexing gently, the

samples were allowed to stand at room temperature for exactly 10
minutes from the time of addition of the antiserum.

Then, the tubes

were transferred to an ice bath for 2 hours.
At the end of the reaction period, 1.0 ml dextran-coated
charcoal solution was pipetted within 1 minute into all the samples
except the TC tubes.

Exactly 10 minutes later the samples were

centrifuged at 2200 g for 10 minutes at 4°C.

The supernatant was

quantitatively decanted into individual scintillation vials already
containing 15 ml Biofluor and 0.70 ml demineralized water.

The vials

were capped, vortexed and refrigerated until a clear homogeneous
solution appeared at which time they were counted for 20 minutes.
All values for urinary prostaglandin E2 were corrected for
losses incurred through extraction and chromatography.

In all the

steps prior to radioimmunoassay prostaglandin E-j and prostaglandin E2
are indistinguishable; therefore, yield was estimated as percent of
•3

total recovery of added

H-prostaglandin Ej.

The affinity, specificity, and sensitivity parameters of the
Pasteur anti-prostaglandin E2 antiserum have been published.^
Because of the weak cross reactivity of the antiserum with prosta¬
glandin E-j (2.7%),^ no correction was made for the tracer amount of
^H-prostaglandin E] added for recovery measurements.
Percent of trace binding was calculated as the fraction of
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initial binding (Bq).

Both values were corrected for nonspecific

binding (NSB); that is,

%

trace binding =

x • NSB x 100
Bq

”N5b

where x is the binding of the standard or test sample.
the resulting values were plotted on a log-logit scale.

For standards
Percent

trace binding for the test samples was determined from the above
equation and the amount of prostaglandin E2 read off the abscissa.
For determination of quenching, duplicate scintillation vials
o

containing approximately 30,000 cpm °H-prostaglandin E2 were counted
with 15 ml Biofluor alone and after the introduction of 0.70 ml
demineralized water and 1.3 ml phosphosaline buffer with gelatin.
Percent quenching was calculated from the formula

^ =

cPm(Biofluor) - cpm(Biofluor:H?0:PSBG)
cPm(Biofluor)
X

Background was assessed as cpm for a Biofluor:water:phosphosaline
buffer with gelatin mixture without tritiated prostaglandin.
Materials
Sprague-Dawley rats were ordered from Charles River (Boston,
MA).

Brattleboro rats were from the colony of Dr. John N. Forrest,

Jr.
Vasopressin tannate suspension 4n peanut oil for intramuscular
injection was furnished by Park, Davis and Company (Detroit, MI).
Inactin came from Hamburg, Germany.
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Unlabel led prostaglandins for standards were generously
supplied by Dr. John L. Pike of the Upjohn Company (Kalamazoo, MI).
Tritiated prostaglandin E-j{( 5,6(n)-^H} -prostaglandin E], Code
TRK.426, Batch 12) was a product of the Amersham Searle Corporation
(Atlington Heights, IL).

Tritiated prostaglandin E2, Lot 932 122)

came from the New England Nuclear Company (Boston, MA).

Both radio¬

active prostaglandins were purified by silicic acid column chromato¬
graphy (see methods) within two weeks of use.

All prostaglandins

were stored in ethanol under nitrogen at -20°C.
Thin layer chromatography plates were prescored silica gel
GF 250 v thick from New England Nuclear.
In all cases ethanol was absolute ethyl alcohol purchased
from U.S. Industrial Chemicals Company (New York, NY).

Organic

solvents were Mallinckrodt SpectrAR grade unless otherwise indicated
and were used without further purification.

Concentrated hydro¬

chloric acid 37% (w/v) was obtained from Mallinckrodt, Incorporated
(St. Louis, MO).

All water was demineralized by passage through a

D 5041 mixed resin filter of the Barnstead Sybron Corporation.
Sodium chloride (NaCl) and sodium hydroxide (NaOH) were
reagent grade chemicals from Mallinckrodt.

Sodium dihydrogen phos¬

phate Monohydrate (NaH2P04.HgO), reagent grade, came from Fischer
Scientific Company (Fair Lawn, NJ).

Practical grade sodium azide

(Naf^) was provided by the Matheson, Coleman and Bell Manufacturing
Chemists, Norwood, OH).
(Detroit, MI).

Gelatin was obtained from Difco Laboratories
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Amberlite CG-50, 100 to 200 mesh, and silicic acid, 100 mesh,
were products of Mai 1inckrodt.

Prior to chromatography, silicic acid

was washed three times with four volumes methanol to remove fines,
dried in an oven at 40°C, and stored in a dessicator.
Phosphosaline buffer consisting of 0.10 M phosphate and 0.90%
(w/v) NaCl with 0.10% (w/v) NaNg as preservative was brought up to
pH 7.40 with NaOH.

On day of radioimmunoassay, phosphosaline buffer

with 0.10% (w/v) gelatin was prepared by dissolving 1 mg gelatin per
1 ml phosphosaline buffer over low heat and then cooling slowly to
room temperature.
Dextran-coated charcoal was made by combining 300 mg Norit A
(Fischer Scientific Company) with 100 ml phosphosaline buffer with
gelatin at 0°C on a magnetic stirrer.

When the charcoal had become

nomogeneously dispersed in buffer, 30 mg Dextran T 70, Pharmacia
(Uppsala, Sweden) was added.

The mixture was stirred continuously

and kept at 0°C for 30 minutes before and during use.
Anti-prostaglandin E^ antiserum (immunogenrprostaglandin E2bovine serum albumin, animal:

rabbit. Code 79 585 - Lot C) came in

lyophylized form from Dr. F. Dray, Institut Pateur (Paris, France).
The antiserum was stored at 4°C.

At the time of assay the antibody

was dissolved in 11.0 ml chilled phosphosaline buffer with gelatin
and held at 0°C.
All centrifugations took place in a Sorvall RC-2 centrifuge
manufactured by the Dupont Company (Norwalk, CT).
for the respective experiments.

Speeds are noted
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Osmolalities were measured by freezing point depression on an
osmomete from Advanced Instruments, Incorporated (Needham Heights,
MA).
Evaporation under nitrogen was carried out on an N-Evap
analytical evaporator by Organomation Associates, Incorporated
(Shrewsbury, MA).
Assessment of radioactivity was performed in a refrigerated
(2°C) Packard Tri-Carb Liquid Scintillation Spectrometer Model 3320
(Downers Grove, IL).

Scintillation fluid was Aquasol or Biofluor

as specified from New England Nuclear.

Times for counts are indicated

for each determination.
Creatinine was measured employing a modification of the pro¬
cedure of Folin and Wu on an Autoanalyzer, Technicon Corporation
(Chauncey, NY).

Results
Effects of storage temperature and time on the stability of prosta¬
glandin E? in rat urine
The thin layer chromatography experiments were designed to assess
the optimal temperature for timed urine collections and storage of
specimens in order to minimize loss of prostaglandin E2 by conversion
to prostaglandin A2.
three temperatures:

The proportion of conversion was examined at
room temperature (22° ± 3°C), refrigerator

temperature (4°C), and freezer temperature (-20°C).

Since the parti¬

tion coefficient for extraction of prostaglandins from aqueous to
organic media is pH dependent, urine of identical pH (pH 6.3) from a
single urine collection was used in all thin layer chromatography
experiments (except Control #2).

The relative amounts of tritiated

prostaglandin in the prostaglandin E2 and the prostaglandin ^ zones
was calculated as the percent of total recovered radioactivity for
the given sample and are listed in Table 2.
After one hour, the radioactivity present in the prostaglandin k^
zone of samples at any of the three temperatures did not differ
substantially from the amount of radioactivity detected in the
prostaglandin A2 zone of Control #1 plated without processing through
urine.

The amounts of tracer found in the prostaglandin A2 zone at

room temperature, 4°C and -20°C were 4%, 5% and 2% of total radio¬
activity, respectively.

However, 4% of the tritiated prostaglandin

in Control #1 was eluted from the prostaglandin

zone.

From Figure 4 it can be appreciated that samples kept at 4°C and
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-20°C showed no change in the proportion of tracer converted to
prostaglandin A2 after a lapse of 24 hours, but at room temperature
17% of the added
glandin A2 zone.

■5

H-prostaglandin E2 was recovered from the prosta¬
After 48 hours still no alteration in the distribu¬

tion of tracer was discernible in the samples at 4°C and -20°C;
however, following two weeks at 4°C this specimen contained 20% of
the recovered labeled prostaglandin in the prostaglandin A2 band.
The percent of

H-prostaglandin E2 recovered from the prostaglandin

E2 zone of this sample concomitantly decreased to 20% whereas in
previous specimens the percent tracer in the prostaglandin E2 band
ranged from 65% to 36% (Table 2).

Even after two weeks of storage

at -2Q°C, the percent of tritiated prostaglandin in the prostaglandin
A2 zone (3%) did not differ from that in Control #1 (4%).
To evaluate the capability of thin layer chromatography to
detect tracer amounts of prostaglandin A2 produced from prostaglandin
E2 a positive control (Control #2) was prepared by adjusting the
urine to pH 3 which is known to facilitate nonenzymatic conversion of
prostaglandin E2 to prostaglandin A2.

3

After thus treating the

samples, 23% (4°C) to 31% (RT) of the tritiated prostaglandin was
eluted from the prostaglandin A2 zone; the 3H~prostaglandin E2 re¬
maining in the prostaglandin E2 band decreased to 36% (4°C) and 41%
(RT).

For both these controls tn equaled ten minutes.
To avoid artifactually inducing conversion of prostaglandin

E2 to prostaglandin A2 in the test urines none of these urines were
acidified before extraction and plating.

Hence, recovery of total

inoculated JH-prostaglandin E2 after extraction, chromatography, and
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elution varied over a wide range:

-

12.1% to 51.2%.

Effects of endogenous antidiuretic hormone on urine osmolality and
urinary excretion of prostaglandin E? in the Sprague-Dawley rat
Dehydration of normal Sprague-Dawley rats was utilized to
examine the effect of endogenous antidiuretic hormone secretion on
urinary excretion of prostaglandin E2.

Average body weights of the

rats at the inception of the experiment was 265 ± 3 gm.

After eight

days of sodium loading body weight averaged 306 ± 4 gm, an increase
of 13.6 ± 0.9%.
As indicated in Table 3, urine flow during the 18th through
30th hours of dehydration was 6.1 ± 0.4 pi per minute which was a
significant decrease (p< 0.005) from the baseline value, 13 ± 1.4 pi
per minute.

Predictably, urinary osmolality increased from 1268 ± 70

mQsm per kg at baseline to a maximum 2673 ± 132 mOsm per kg after de¬
hydration (p <0.001).

Despite a marked reduction in urine flow, 12

hour excretion of prostaglandin E2 increased from 7.9 ± 0.7 ng to
11.2 ± 0.9 ng (p < 0.05).

Urinary creatinine excretion did not

change significantly with dehydration.
Effects of exogenous vasopressin on urinary prostaglandin E2 excretion
in the Brattleboro rat
The effect of daily low dose exogenous vasopressin on renal
water metabolism and excretion of prostaglandin E2 was observed over
seven days.

Table 4 shows the serial changes in urine flow, urinary

osmolality, and urinary excretion of prostaglandin
Over the course of vasopressin administration flow progressively
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decreased while urinary osmolality concomitantly increased.

There

was an initial profound drop in flow from 73 ± 3 y1 per minute to
43 ± 7 ul per minute after one day of vasopressin (p < 0.005).
Further decreases in urine flow on days 4 and 7 were not significant
when compared to the values on days 1 and 4. respectively.
Urine osmolality in the absence of antidiuretic hormone was
99 ± 8 mOsm per kg.

Throughout the period of vasopressin administra¬

tion there was continually statistically significant increments in
urine osmolality reaching 860 ± 80 mOsm per kg on day 7.
Increases in urinary excretion of prostaglandin E£ paralleled
the changes in urine osmolality with a coefficient of correlation
equaling 0.80 (see Figure 5).

Twenty-four hour urinary output of

prostaglandin E2 after one day of vasopressin increased fourfold from
6.9 ± 3.6 ng at baseline to 29.3 ± 4.7 ng on day 1 (p< 0.005).
UV(ipGE^ again doubled by day 4 to 61.4 ± 9.2 ng (p<0.01).

There was

no further change in urinary excretion of prostaglandin E2 on day 7
despite the persistent rise in urine osmolality and fall in urine
flow.
Creatinine clearance for nine rats was 1.16 ± 0.06 ml per
minute.
Effect of dehydration alone on urine osmolality and urinary prosta¬
glandin E? excretion in the Brattleboro rat
To examine if dehydration alone in the absence of antidiuretic
hormone is sufficient to increase urinary excretion of prostaglandin
E2, Brattleboro rats were subjected to 16 hours of water deprivation.
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Four hours after water had been withdrawn body weight had fallen by
5.7

0.6%.

By the 16th hour of dehydration 15.5%

body weight was lost.

1.0% of initial

Average creatinine clearance for nine animals

at the end of dehydration was 1.60

0.14 ml per minute.

Baseline urine osmolality (108 ± 6 mOsm per kg) was consistent
with congenital diabetes insipidus; likewise, baseline urine flow was
96 ± 8 yl per minute.

With dehydration urine osmolality rose to

502 ± 56 mOsm per kg (p< 0.001) and flow decreased to 17 ± 1.4 u1 per
minute (p <0.001).

Twelve hour urinary excretion of prostaglandin E2

was 7.9 ± 1.5 ng at baseline.

In the dehydrated animal UVpQ^ in¬

creased to 23.3 ± 2.8 ng (P<0.001).
Quantitation of urinary prostaglandin Eg by radioimmunoassay
A typical standard curve for the radioimmunoassay of prosta¬
glandin E2 is depicted in Figure 6.
of trace binding.

Nonspecific binding was 4.6± 1.25

The phosphosaline buffer blank in each assay dis¬

placed less than 0.1% of bound radioactivity and thus was consistently
outside the limits of the standard curve.

The control with 1 ng

prostaglandin E2 in phosphosaline buffer gave 0.97 ± 0.10 ng by assay.
Quenching was checked with each assay and remained stable at 15.9 ± 0.4%.
Each value for urinary prostaglandin E2 was individually corrected
for loss during extraction and chromatographic procedures; average
recovery was 38.6 ± 1.2%.

Discussion
Conservation of water by the mamnalian kidney during periods
of water deprivation or plasma hyperosmolality requires the presence
of vasopressin and its effective action on the collecting duct in
addition to the establishment and preservation of a hypertonic
medullary interstitium.
The studies here have demonstrated that in saline-expanded
Sprague-Dawley rats dehydration is a stimulus for renal production
and excretion of prostaglandin

In normal rats, dehydration is

a potent stimulus for the secretion of antidiuretic hormone; however,
other substances such as catecholamines and angiotensin II, which
themselves influence renal synthesis of prostaglandin E2J*
are released as well.

For example, acute hemorrhagic loss of 20% of

blood volume in anesthesized dogs increased renal prostaglandin E2;
this increase was attributed to release of angiotensin II and in¬
creased renal nerve activity.77*

During hemorrhagic shock, sub¬

stances known to affect renal prostaglandin E2 such as angio¬
tensin,^*

kinins, ^4 and norepinephrine63 are secreted in

addition to antidiuretic hormone, thus making the change in prosta¬
glandin E2 excretion difficult to attribute to any single agent.
Furthermore, we have demonstrated that marked dehydration in the
absence of antidiuretic hormone increases urinary excretion of
prostaglandin E2.

Although it is important to note that the degree

of dehydration which accompanied the rise in renal prostaglandin E2
is never achieved in rats with normal antidiuretic hormone secretory
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function, it is nevertheless impossible to conclude unequivocally
that in vivo stimulation of endogenous antidiuretic hormone would
result in a quantifiable and significant rise in renal synthesis and
urinary excretion of prostaglandin E2.
However, there is convincing in vitro evidence that prosta¬
glandin E2 synthesis by renomedul1 ary interstitial cells in tissue
culture is stimulated by the presence of vasopressin

In a

recent abstract, Stein and Lifschitz reported that vasopressin ad¬
ministered to normal rabbits in vivo is associated with an increased
urinary prostaglandin E2 excretion.^

Another preliminary study by

Valtin and co-workers also found a rise in urinary excretion of
prostaglandin E2 after exogenous vasopressin was given for two days
AO

to Brattleboro rats.

The low doses of vasopressin administered in

these in vivo studies still provided a higher level of the hormone
than under normal physiological conditions of dehydration or states
of plasma hyperosmolality.

In light of these reports by other in¬

vestigators, our data are consistent with, but do not conclusively
prove, the hypothesis that endogenous antidiuretic hormone in itself
may stimulate renal production of prostaglandin E2.
If decreased intravascular volume were the sole factor involved
in stimulating renal synthesis of prostaglandin E2, Brattleboro rats,
which are chronically in negative water balance and mildly volume
contracted and have elevated plasma renin levels,^ might be expected
to show little change in urinary excretion of prostaglandin E2 with
exogenous vasopressin administration.

However, our results indicate

that these antidiuretic hormone-deficient rats have an acute rise in
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urinary excretion of prostaglandin E2 one day after low dose vaso¬
pressin.

Significantly, prostaglandin E2 excretion continues to rise

for four days and is sustained at the new level while the rats' total
body water is restored to normal.

Frolich and colleagues have pub¬

lished preliminary data that shows this rise in renal production of
prostaglandin E2 is still evident after thirty days of exogenous vaso¬
pressin.^
Although when prostaglandin E2 production is inhibited in
conscious dogs there is no change in basal renal blood flowJ48 we
may speculate that profound dehydration evokes an acute renal vaso¬
constrictor response which in turn may stimulate urinary prostaglandin
E2 excretion.

This does not preclude the possibility that prosta¬

glandin E2 may act at the late distal convoluted tubule and collecting
duct to regulate the cellular action of vasopressin.

In fact, both

actions of prostaglandin E2 may be important for the optimal main¬
tenance of water balance.
Since the available studies on urinary prostaglandin E2 and
vasopressin have appeared in abstract form,48» 64, 99 tjie conditions
for collection and storage of urine specimens prior to radioimmuno¬
assay are not provided.

The importance of collecting blood samples

under strict conditions to avoid prostaglandin release from platelets
has been stressed by Dray and co-workers.44

we have systematically

examined the conversion of prostaglandin E2 to prostaglandin ^ in
rat urine and shown that collection at room temperature for 24 hours
results in significant loss of prostaglandin E2.

Hence, the condi¬

tions for collection and storage of urine specimens for radioimmuno-
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assay of prostaglandin E2 must be strictly controlled.

It is

recommended that 24 hour urines be collected at ice-water temperature
and subsequently stored at -20°C until assay.
In summary, both endogenous and exogenous vasopressin stimu¬
lates renal production and urinary excretion of prostaglandin E2.
However, renal prostaglandin

produced in response to other stimuli

such as dehydration may further modulate the cellular action of anti¬
diuretic hormone on the collecting duct in states of altered water
balance.

The importance of collecting and storing urine for radio¬

immunoassay of prostaglandin E2 under strictly controlled conditions
which prevent chemical conversion of prostaglandin E2 to prostaglandin
A2 has been demonstrated.
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Table 1
Standard Curve for Radioimmunoassay
of Prostaglandin E2
Standard No.

Quantity PGE?

Stock Solution No.

(pg)
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Table 3
Effects of Endogenous Antidiuretic Hormone on Urine Osmolality and
Urinary Excretion of Prostaglandin E2 in the Sprague Dawley Rat.
Baseline

Post Dehydration

P

6.1±0.4

<0.005

1268±70

2673±132

<0.001

upge2 (pg/mi)

851±71

2628±298

<0.005

UVrqe

7.9±0.7

11.2±0.9

<0.05

13±1.4

Flow (yl/min)
Osmolality (mOsm/kg H2O)

(ng/12 hr)

All values given

±

S.E. (standard error)
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Table 5
Effect of Dehydration Alone on Urine Osmolality and
Urinary Excretion of Prostaglandin E2 in the Brattleboro Rat

Flow (yl/min)

Baseline

Post Dehydration

96±8

17±1.4

(n=ll)

P
<0.001

Osmolality (mOsm/kg H2O)

108±6

502±56

<0.001

UPGe2 (pg/ml)

143±45

1935±250

<0.001

UVPGE2 (n9/12 hr)

7.9±1.5

23.3±2.8

<0.001

All values given

±

S.E. (standard error)
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